%0 Journal Article
%T Durable clinical benefit from afatinib in a lung adenocarcinoma patient with acquired EGFR L718V mutation-mediated resistance towards osimertinib: a case report and literature review
%A Song, Zizheng
%A Ren, Guanying
%A Wang, Xiaolei
%A Du, Haiwei
%A Sun, Ying
%A Hu, Ling
%J Annals of Palliative Medicine
%D 2022
%B 2022
%9 
%! Durable clinical benefit from afatinib in a lung adenocarcinoma patient with acquired EGFR L718V mutation-mediated resistance towards osimertinib: a case report and literature review
%K 
%X 
%U https://apm.amegroups.org/article/view/90118
%V 11
%N 3
%P 1126-1134
%@ 2224-5839